Evolent Health is a health information service company located in Virginia, United States, which is part of the Healthcare sector, and is traded under the ticker EVH on the NYSE exchange.
Evolent Health stock last closed at $9.86, up 0.2% from the previous day, and has decreased 64.46% in one year. It has overperformed other stocks in the Health Information Services industry by 0.07 percentage points. Evolent Health stock is currently +18.08% from its 52-week low of $8.35, and -70.68% from its 52-week high of $33.63.
There are currently 116.59M shares of EVH outstanding. The market cap of EVH is $1.15B. In the last 24 hours, 1.6M EVH shares were traded.
How to Buy Evolent Health Stock
Wondering how to invest in Evolent Health stock? Here's how.
Choose where to buy Evolent Health stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Evolent Health stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit money your investment account: Choose your payment method and add your info.
Research Evolent Health stock: The Evolent Health ticker symbol is EVH. Is Evolent Health stock a good investment? Should you buy shares of EVH? How do EVH's underlying business fundamentals look? Do top analysts think Evolent Health is a good buy? Why has EVH's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if EVH is a good stock to buy).
Place your EVH trade: Decide if you will purchase EVH shares at the current market price or use a limit order to buy EVH shares at a particular price.
Get notifications regarding your EVH position: Create a watchlist to key updates about your investment in Evolent Health stock.
Step 1: Choose where to buy Evolent Health stock
You will need a brokerage account to access the NYSE market and buy EVH shares.
A brokerage account allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to global markets: From Tech to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal information so you are able to invest in EVH today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Evolent Health stock
After you have figured out the best place to buy Evolent Health stock, it's important to evaluate their stock prior to investing, so you actually comprehend the risk and opportunity.
Evolent Health Metrics
EVH Price
$9.86
1w %
9.8%
1y %
-64.46%
5y %
36.75%
P/E
-12.17x
P/B
1.15x
P/S
0.44x
PEG
N/A
Revenue
$2.55B
Earnings
-$93.45M
Fore. Rev. Growth
3.46%
Fore. Earn. Growth
N/A
Market Cap
$1.15B
Next Earnings
Jun 6, 2025
Next Dividend
N/A
Evolent Health Due Diligence Checks
WallStreetZen was built to help part-time investors do better fundamental analysis in less time.
You can view all of the due diligence checks on EVH's stock page.
Is EVH stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge EVH's fair value.
Using relative valuations ratios:
EVH could be undervalued based on its P/B ratio of 1.15x, relative to Health Information Services industry P/B ratio of 3.52x
EVH has $163.50M in cash and short term investments. This is sufficient to cover its annual cash burn of $6.13M.
EVH profit margin has gone up from -7.2% to -3.7% in the past year.
EVH has cash burn of 6128000. It has enough cash and short-term investments to cover this for at least one year.
Negative Financial Indicators:
There are more long-term liabilities than short-term assets on the EVH balance sheet.
Total EVH debt is higher than 5 years ago, relative to shareholder equity.
EVH has a relatively high debt to equity ratio of 1.35.
There are more short-term liabilities than short-term assets on the EVH balance sheet.
Is Evolent Health stock a Buy, Hold, or Sell, according to analysts?
Out of 13 Wall Street analysts who track EVH, the consensus analyst rating on EVH is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
Most Recent EVH Analyst Upgrades/Downgrades
Jeff Jones, a bottom 16% analyst from Oppenheimer maintains EVH with a buy rating and lowers their EVH price target from $28.00 to $18.00, on Jan 24, 2025.
Richard Close, a bottom 3% analyst from Canaccord Genuity maintains EVH with a strong buy rating and lowers their EVH price target from $23.00 to $16.00, on Jan 23, 2025.
Jeff Garro, a bottom 8% analyst from Stephens & Co. maintains EVH with a hold rating and lowers their EVH price target from $16.00 to $12.00, on Jan 21, 2025.
Kevin Caliendo, a top 14% analyst from UBS maintains EVH with a strong buy rating and lowers their EVH price target from $27.00 to $14.00, on Jan 16, 2025.
Sean Dodge, a top 17% analyst from RBC Capital maintains EVH with a buy rating and lowers their EVH price target from $20.00 to $17.00, on Jan 14, 2025.
Last year, EVH revenue was $2.55B. In the last five year, EVH's revenue has grown by 30.04% per year. This was faster than the Health Information Services industry average of 21.98%.
No, Evolent Health doesn't provide an income stream by paying out dividends.
What others are saying about EVH
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your EVH trade
There are two primary order types:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are usually the easiest way to buy.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a given price limit, place a limit order.
Click the Open Trade button and eToro will execute the order.
If you require additional assistance buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Evolent Health share?
As of Apr 30, 2025, it costs $9.86 to buy one share of Evolent Health stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $4, you can buy 0.406 shares of EVH.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.